LEADER 01568oam  2200457   450 
001 9910707357703321
005 20160719093938.0
035   $a(CKB)5470000002463940
035   $a(OCoLC)953721126
035   $a(OCoLC)995470000002463940
035   $a(EXLCZ)995470000002463940
100   $a20160719d1991      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aPromotion of prescription drugs through payments and gifts
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d[1991]
215   $a1 online resource (43 unnumbered pages) $cillustrations
300   $aTitle from title screen (viewed July 15, 2016).
300   $a"8/91"--OIG web site.
300   $a"OEI-01-90-00480."
320   $aIncludes bibliographical references (pages D-1-D-4).
606   $aDrugs$zUnited States$xMarketing
606   $aSales promotion$zUnited States
606   $aPhysicians$zUnited States$xFinance, Personal
606   $aBusiness ethics$zUnited States
606   $aCorporations$xCorrupt practices$zUnited States
615  0$aDrugs$xMarketing.
615  0$aSales promotion
615  0$aPhysicians$xFinance, Personal.
615  0$aBusiness ethics
615  0$aCorporations$xCorrupt practices
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707357703321
996   $aPromotion of prescription drugs through payments and gifts$93291662
997   $aUNINA